CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact

Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: NDE1 (ImmuneEditome ID:54820)

1. Gene summary of enriched editing regions for NDE1

check button Gene summary
Gene informationGene symbol

NDE1

Gene ID

54820

GeneSynonymsHOM-TES-87|LIS4|MHAC|NDE|NUDE|NUDE1
GeneCytomap

16p13.11

GeneTypeprotein-coding
GeneDescriptionnuclear distribution protein nudE homolog 1|LIS1-interacting protein NUDE1, rat homolog|epididymis secretory sperm binding protein|nudE nuclear distribution E homolog 1|nudE nuclear distribution gene E homolog 1
GeneModificationdate20230517
UniprotIDI3L2T8;I3L3G9;Q9NXR1;I3L2S8;X5DR54;I3L533;I3L464;I3L2R9;A0A6Q8PEY3;I3L522;A0A0J9YYF5;A0A6Q8PGV6;A0A6Q8PHH1;A0A6Q8PG46
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr16:15654405-15654582:+ENST00000396354.4ENSG00000072864.11NDE1intronicAluSxchr16:15654405-15654582:+.alignment
chr16:15654405-15654582:+ENST00000396355.4ENSG00000072864.11NDE1intronicAluSxchr16:15654405-15654582:+.alignment
chr16:15654405-15654582:+ENST00000570727.4ENSG00000072864.11NDE1intronicAluSxchr16:15654405-15654582:+.alignment
chr16:15654405-15654582:+ENST00000572756.4ENSG00000072864.11NDE1intronicAluSxchr16:15654405-15654582:+.alignment
chr16:15654405-15654582:+ENST00000573203.4ENSG00000072864.11NDE1intronicAluSxchr16:15654405-15654582:+.alignment
chr16:15670497-15671444:+ENST00000342673.8ENSG00000072864.11NDE1intronicAluJo,L1ME2z,AluSpchr16:15670497-15671444:+.alignment
chr16:15670497-15671444:+ENST00000396354.4ENSG00000072864.11NDE1intronicAluJo,L1ME2z,AluSpchr16:15670497-15671444:+.alignment
chr16:15670497-15671444:+ENST00000396355.4ENSG00000072864.11NDE1intronicAluJo,L1ME2z,AluSpchr16:15670497-15671444:+.alignment
chr16:15670497-15671444:+ENST00000570727.4ENSG00000072864.11NDE1intronicAluJo,L1ME2z,AluSpchr16:15670497-15671444:+.alignment
chr16:15670497-15671444:+ENST00000572756.4ENSG00000072864.11NDE1intronicAluJo,L1ME2z,AluSpchr16:15670497-15671444:+.alignment
chr16:15670497-15671444:+ENST00000573203.4ENSG00000072864.11NDE1intronicAluJo,L1ME2z,AluSpchr16:15670497-15671444:+.alignment
chr16:15689671-15690276:+ENST00000342673.8ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15689671-15690276:+ENST00000396354.4ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15689671-15690276:+ENST00000396355.4ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15689671-15690276:+ENST00000572756.4ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15689671-15690276:+ENST00000573203.4ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15689671-15690276:+ENST00000574109.4ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15689671-15690276:+ENST00000577101.4ENSG00000072864.11NDE1intronicAluSx,AluSz6chr16:15689671-15690276:+.alignment
chr16:15697039-15697557:+ENST00000342673.8ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15697039-15697557:+ENST00000396354.4ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15697039-15697557:+ENST00000396355.4ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15697039-15697557:+ENST00000572967.1ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15697039-15697557:+ENST00000573694.4ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15697039-15697557:+ENST00000574109.4ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15697039-15697557:+ENST00000576502.4ENSG00000072864.11NDE1intronicAluSz,AluJbchr16:15697039-15697557:+.alignment
chr16:15699290-15701319:+ENST00000572967.1ENSG00000072864.11NDE1exonicAluSx,AluSz6,AluJb,AluSz,MIR3chr16:15699290-15701319:+.alignment
chr16:15699290-15701319:+ENST00000573694.4ENSG00000072864.11NDE1exonicAluSx,AluSz6,AluJb,AluSz,MIR3chr16:15699290-15701319:+.alignment
chr16:15699290-15701319:+ENST00000574109.4ENSG00000072864.11NDE1exonicAluSx,AluSz6,AluJb,AluSz,MIR3chr16:15699290-15701319:+.alignment
chr16:15699290-15701319:+ENST00000576502.4ENSG00000072864.11NDE1exonicAluSx,AluSz6,AluJb,AluSz,MIR3chr16:15699290-15701319:+.alignment


Top

2. Tumor-specific enriched editing regions for NDE1


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
ENSG00000072864.11,NDE1BRCAEAG1.2302e-02image
ENSG00000072864.11,NDE1PRADEAG1.8170e-02image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot
chr16:15699290-15701319:+CHOLEER2.5334e-022.0149e-031.2097e+11image
ENSG00000072864.11,NDE1CHOLEAG2.5334e-022.0149e-031.2097e+11image
ENSG00000072864.11,NDE1LAMLEAG1.1853e-024.6043e-022.0421e+01image

Top

3. Enriched editing regions and immune related genes for NDE1


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr16:15699290-15701319:+UCECEERENSG00000145388,METTL14-0.33243.8248e-032.5686e-08-0.4100imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPD;HNRNPM;HNRNPU;IGF2BP2;METTL3;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1METTL14T_cells_CD4_memory_restingGSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000226396,RP5-1056L3.30.31477.0273e-033.1806e-160.5717imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000232573,RPL3P40.29821.2143e-024.9535e-110.4755imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000174788,PCP20.29051.3575e-022.6548e-080.4096imageNBCCIP;EIF4A3;FUS;HNRNPU;SF3B4;TAF15NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000254432,RP11-33I11.20.27311.6355e-026.1786e-200.6253imageNNNAT_cells_CD4_memory_restingGSVA_HALLMARK_PEROXISOME
chr16:15699290-15701319:+UCECEERENSG00000252202,Y_RNA0.27612.0755e-021.0865e-170.5940imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ANDROGEN_RESPONSE
chr16:15699290-15701319:+UCECEERENSG00000101940,WDR130.27892.1310e-022.6277e-080.4097imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPM;HNRNPU;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_TGF_BETA_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000236058,RP11-215A21.20.27802.2386e-023.6655e-120.4992imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000272330,AC002044.40.26512.3415e-024.0713e-170.5855imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000274383,CTD-2017F17.20.27382.4751e-028.5436e-200.6234imageNIGF2BP2NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000145388,METTL14-0.33243.8248e-032.5686e-08-0.4100imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPD;HNRNPM;HNRNPU;IGF2BP2;METTL3;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1METTL14T_cells_CD4_memory_restingGSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000226396,RP5-1056L3.30.31477.0273e-033.1806e-160.5717imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000232573,RPL3P40.29821.2143e-024.9535e-110.4755imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000174788,PCP20.29051.3575e-022.6548e-080.4096imageNBCCIP;EIF4A3;FUS;HNRNPU;SF3B4;TAF15NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000254432,RP11-33I11.20.27311.6355e-026.1786e-200.6253imageNNNAT_cells_CD4_memory_restingGSVA_HALLMARK_PEROXISOME
chr16:15699290-15701319:+UCECEERENSG00000252202,Y_RNA0.27612.0755e-021.0865e-170.5940imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ANDROGEN_RESPONSE
chr16:15699290-15701319:+UCECEERENSG00000101940,WDR130.27892.1310e-022.6277e-080.4097imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPM;HNRNPU;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_TGF_BETA_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000236058,RP11-215A21.20.27802.2386e-023.6655e-120.4992imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000272330,AC002044.40.26512.3415e-024.0713e-170.5855imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000274383,CTD-2017F17.20.27382.4751e-028.5436e-200.6234imageNIGF2BP2NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000145388,METTL14-0.33243.8248e-032.5686e-08-0.4100imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPD;HNRNPM;HNRNPU;IGF2BP2;METTL3;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1METTL14T_cells_CD4_memory_restingGSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000226396,RP5-1056L3.30.31477.0273e-033.1806e-160.5717imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000232573,RPL3P40.29821.2143e-024.9535e-110.4755imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000174788,PCP20.29051.3575e-022.6548e-080.4096imageNBCCIP;EIF4A3;FUS;HNRNPU;SF3B4;TAF15NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000254432,RP11-33I11.20.27311.6355e-026.1786e-200.6253imageNNNAT_cells_CD4_memory_restingGSVA_HALLMARK_PEROXISOME
chr16:15699290-15701319:+UCECEERENSG00000252202,Y_RNA0.27612.0755e-021.0865e-170.5940imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ANDROGEN_RESPONSE
chr16:15699290-15701319:+UCECEERENSG00000101940,WDR130.27892.1310e-022.6277e-080.4097imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPM;HNRNPU;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_TGF_BETA_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000236058,RP11-215A21.20.27802.2386e-023.6655e-120.4992imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000272330,AC002044.40.26512.3415e-024.0713e-170.5855imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000274383,CTD-2017F17.20.27382.4751e-028.5436e-200.6234imageNIGF2BP2NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000145388,METTL14-0.33243.8248e-032.5686e-08-0.4100imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPD;HNRNPM;HNRNPU;IGF2BP2;METTL3;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1METTL14T_cells_CD4_memory_restingGSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000226396,RP5-1056L3.30.31477.0273e-033.1806e-160.5717imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION
chr16:15699290-15701319:+UCECEERENSG00000232573,RPL3P40.29821.2143e-024.9535e-110.4755imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000174788,PCP20.29051.3575e-022.6548e-080.4096imageNBCCIP;EIF4A3;FUS;HNRNPU;SF3B4;TAF15NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000254432,RP11-33I11.20.27311.6355e-026.1786e-200.6253imageNNNAT_cells_CD4_memory_restingGSVA_HALLMARK_PEROXISOME
chr16:15699290-15701319:+UCECEERENSG00000252202,Y_RNA0.27612.0755e-021.0865e-170.5940imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_ANDROGEN_RESPONSE
chr16:15699290-15701319:+UCECEERENSG00000101940,WDR130.27892.1310e-022.6277e-080.4097imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPM;HNRNPU;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_TGF_BETA_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000236058,RP11-215A21.20.27802.2386e-023.6655e-120.4992imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr16:15699290-15701319:+UCECEERENSG00000272330,AC002044.40.26512.3415e-024.0713e-170.5855imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_MTORC1_SIGNALING
chr16:15699290-15701319:+UCECEERENSG00000274383,CTD-2017F17.20.27382.4751e-028.5436e-200.6234imageNIGF2BP2NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_PROTEIN_SECRETION

More results



Top

4. Enriched editing regions and immune related splicing for NDE1


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr16:15699290-15701319:+
DLBCEERIRENSG00000168067.7chr1164797274:64797380:64797500:64797534-0.72271.3455e-021.1491e-05-0.6149imageNBCCIP;CSTF2T;DGCR8;EIF4A3;FAM120A;FUS;HNRNPA2B1;HNRNPM;HNRNPU;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1MAP4K2Dendritic_cells_resting
ENSG00000072864.11,NDE1
DLBCEAGIRENSG00000168067.7chr1164797274:64797380:64797500:64797534-0.72271.0138e-021.1491e-05-0.6149imageNADAR;BCCIP;BUD13;CELF2;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DKC1;EIF4A3;EIF4G2;ELAVL3;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LIN28;LIN28B;LSM11;MOV10;MSI2;NOP56;NOP58;PCBP2;PRPF8;PTBP1;RBFOX2;RBM10;RBM27;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZNF184MAP4K2Dendritic_cells_resting
chr16:15699290-15701319:+
TGCTEERESENSG00000143164.11chr1168004736:168004793:168015780:168015951:168022987:1680230470.25418.8264e-039.9382e-070.4396imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPD;HNRNPM;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1NAMacrophages_M2GSVA_HALLMARK_MYOGENESIS
ENSG00000072864.11,NDE1
TGCTEAGMEXENSG00000139971.11chr1458291634:58291707:58293065:58293138:58295745:58295811:58297954:58298139-0.24934.0642e-022.3655e-06-0.4077imageNADAR;CELF2;CNBP;DDX54;DGCR8;DKC1;ELAVL1;ELAVL3;EWSR1;FBL;FMR1;FUS;HNRNPA2B1;HNRNPC;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;KHDRBS2;LIN28A;MBNL2;MOV10;MSI1;NOP56;NOP58;PTBP1;RBFOX2;TAF15;TARDBP;U2AF2;UPF1;YTHDC1NAMacrophages_M2GSVA_HALLMARK_UV_RESPONSE_DN
chr16:15699290-15701319:+
TGCTEERESENSG00000167323.5chr114083262:4083498:4084672:4084765:4086476:40865430.28171.1161e-021.7638e-070.4358imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPM;IGF2BP2;METTL3;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1STIM1Macrophages_M2GSVA_HALLMARK_MYOGENESIS
chr16:15699290-15701319:+
TGCTEERMEXENSG00000139971.11chr1458291634:58291707:58293065:58293138:58295745:58295811:58297954:58298139-0.24934.2921e-022.3655e-06-0.4077imageNDGCR8;ELAVL1;FUS;HNRNPA2B1;HNRNPM;IGF2BP2;NOP56;NOP58;PTBP1;TAF15;YTHDC1NAMacrophages_M2GSVA_HALLMARK_UV_RESPONSE_DN
ENSG00000072864.11,NDE1
TGCTEAGA3ENSG00000073921.13chr1185981128:85981228:85976622:85976682:85976622:85978093-0.36181.0263e-031.9050e-08-0.4391imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LIN28;LIN28A;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM5;RC3H1;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184PICALMB_cells_naiveGSVA_HALLMARK_ESTROGEN_RESPONSE_LATE
ENSG00000072864.11,NDE1
TGCTEAGIRENSG00000130985.12chrX47193828:47197024:47198802:47198919-0.24524.1122e-025.7238e-08-0.4574imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FKBP4;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LIN28;LIN28A;LIN28B;LSM11;METTL3;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM5;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184NAMast_cells_restingGSVA_HALLMARK_UV_RESPONSE_DN
chr16:15699290-15701319:+
TGCTEERIRENSG00000130985.12chrX47193828:47197024:47198802:47198919-0.24524.3416e-025.7238e-08-0.4574imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPD;HNRNPM;HNRNPU;IGF2BP2;METTL3;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1NAMast_cells_restingGSVA_HALLMARK_UV_RESPONSE_DN
chr16:15699290-15701319:+
TGCTEERESENSG00000180900.12chr8143804045:143804156:143804567:143804825:143804954:143805014-0.12874.4125e-024.4394e-07-0.4287imageNBCCIP;CSTF2T;DGCR8;EIF4A3;ELAVL1;FAM120A;FUS;HNRNPA2B1;HNRNPM;HNRNPU;IGF2BP2;NOP56;NOP58;PTBP1;SF3B4;TAF15;TIA1;YTHDC1SCRIBMast_cells_restingGSVA_HALLMARK_UV_RESPONSE_DN

More results



Top

5. Enriched editing regions and immune infiltration for NDE1


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr16:15699290-15701319:+ACCEERNeutrophils9.0942e-03-0.3397image
ENSG00000072864.11,NDE1ACCEAGNeutrophils9.0942e-03-0.3397image
chr16:15699290-15701319:+BLCAEERT_cells_CD4_memory_activated2.2588e-02-0.1165image
ENSG00000072864.11,NDE1BLCAEAGT_cells_CD4_memory_activated6.4115e-03-0.1389image
chr16:15699290-15701319:+BRCAEERMonocytes1.5410e-020.0750image
ENSG00000072864.11,NDE1BRCAEAGT_cells_CD4_memory_activated1.8676e-02-0.0727image
chr16:15699290-15701319:+CESCEERNeutrophils2.8003e-02-0.1262image
ENSG00000072864.11,NDE1CESCEAGNeutrophils2.7928e-02-0.1263image
chr16:15699290-15701319:+CHOLEERT_cells_CD84.2914e-020.3924image
ENSG00000072864.11,NDE1CHOLEAGT_cells_CD84.2914e-020.3924image
chr16:15699290-15701319:+COADEERPlasma_cells1.5722e-02-0.1488image
ENSG00000072864.11,NDE1COADEAGPlasma_cells1.8590e-02-0.1445image
chr16:15699290-15701319:+DLBCEERDendritic_cells_resting1.0694e-02-0.3652image
ENSG00000072864.11,NDE1DLBCEAGDendritic_cells_resting1.0694e-02-0.3652image
chr16:15697039-15697557:+ESCAEERDendritic_cells_resting2.4456e-030.4833image
ENSG00000072864.11,NDE1ESCAEAGT_cells_regulatory_(Tregs)4.7649e-02-0.1568image
chr16:15699290-15701319:+GBMEERT_cells_CD4_memory_resting3.2598e-030.2305image
ENSG00000072864.11,NDE1GBMEAGT_cells_CD4_memory_resting3.1793e-030.2311image
chr16:15699290-15701319:+KIRCEERDendritic_cells_activated4.8864e-020.1099image
chr16:15699290-15701319:+KIRPEERNK_cells_resting3.2104e-030.1919image
ENSG00000072864.11,NDE1KIRPEAGNK_cells_resting3.2104e-030.1919image
chr16:15699290-15701319:+LGGEERT_cells_CD4_memory_resting1.2205e-03-0.1752image
ENSG00000072864.11,NDE1LGGEAGT_cells_CD4_memory_resting1.1967e-03-0.1755image
chr16:15699290-15701319:+LUADEERDendritic_cells_activated2.3007e-02-0.1051image
ENSG00000072864.11,NDE1LUADEAGDendritic_cells_activated2.4716e-02-0.1036image
chr16:15699290-15701319:+LUSCEERMacrophages_M14.8425e-03-0.1261image
ENSG00000072864.11,NDE1LUSCEAGMacrophages_M15.1333e-03-0.1252image
chr16:15699290-15701319:+MESOEERT_cells_regulatory_(Tregs)6.0454e-030.3206image
ENSG00000072864.11,NDE1MESOEAGT_cells_regulatory_(Tregs)6.0454e-030.3206image
chr16:15699290-15701319:+PAADEERT_cells_gamma_delta4.7286e-02-0.1596image
ENSG00000072864.11,NDE1PAADEAGT_cells_gamma_delta4.6582e-02-0.1601image
ENSG00000072864.11,NDE1PCPGEAGNK_cells_resting4.3970e-020.4061image
chr16:15699290-15701319:+PRADEERMast_cells_resting2.2403e-030.1538image
ENSG00000072864.11,NDE1PRADEAGMast_cells_resting5.0445e-040.1736image
chr16:15699290-15701319:+READEERMacrophages_M21.6765e-020.2449image
ENSG00000072864.11,NDE1READEAGMacrophages_M29.6548e-030.2643image
ENSG00000072864.11,NDE1SARCEAGMast_cells_resting3.9809e-040.2218image
chr16:15699290-15701319:+SKCMEERT_cells_gamma_delta1.2340e-020.1156image
ENSG00000072864.11,NDE1SKCMEAGT_cells_gamma_delta1.2118e-020.1159image
chr16:15697039-15697557:+STADEERNeutrophils4.0254e-02-0.3343image
chr16:15699290-15701319:+STADEEREosinophils1.9894e-03-0.1654image
ENSG00000072864.11,NDE1STADEAGEosinophils1.4300e-03-0.1698image
chr16:15699290-15701319:+TGCTEERMast_cells_resting8.4650e-050.3124image
ENSG00000072864.11,NDE1TGCTEAGMast_cells_resting8.4650e-050.3124image
ENSG00000072864.11,NDE1THCAEAGEosinophils3.9626e-030.1443image
chr16:15699290-15701319:+THYMEERT_cells_gamma_delta3.1138e-030.2700image
ENSG00000072864.11,NDE1THYMEAGT_cells_gamma_delta3.1138e-030.2700image
chr16:15699290-15701319:+UCECEERT_cells_regulatory_(Tregs)5.4171e-030.2118image
ENSG00000072864.11,NDE1UCECEAGT_cells_regulatory_(Tregs)5.1334e-030.2131image
chr16:15699290-15701319:+UVMEERB_cells_memory6.9730e-030.3111image
ENSG00000072864.11,NDE1UVMEAGB_cells_memory6.9730e-030.3111image


Top

6. Enriched editing regions and immune gene sets for NDE1


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot
chr16:15699290-15701319:+LIHCEER1.0861e-02image5.6863e-030.2138image
ENSG00000072864.11,NDE1LIHCEAG1.0861e-02image5.6863e-030.2138image


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chr16:15699290-15701319:+COADEER2.1996e-02-0.14125.1737e-03-0.17197.7604e-04-0.20607.4985e-04-0.2066image
ENSG00000072864.11,NDE1COADEAG4.7739e-03-0.17296.3474e-03-0.16732.7215e-04-0.22199.7468e-04-0.2015image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000072864.11,NDE1ACCGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.8568e-03-0.4002image
chr16:15699290-15701319:+ACCGSVA_HALLMARK_MITOTIC_SPINDLEEER1.8568e-03-0.4002image
chr16:15699290-15701319:+BLCAGSVA_HALLMARK_MITOTIC_SPINDLEEER2.5999e-05-0.2131image
ENSG00000072864.11,NDE1BLCAGSVA_HALLMARK_G2M_CHECKPOINTEAG1.9758e-06-0.2399image
chr16:15699290-15701319:+BRCAGSVA_HALLMARK_E2F_TARGETSEER4.6940e-05-0.1256image
ENSG00000072864.11,NDE1BRCAGSVA_HALLMARK_E2F_TARGETSEAG4.8809e-05-0.1252image
ENSG00000072864.11,NDE1CHOLGSVA_HALLMARK_MITOTIC_SPINDLEEAG9.6675e-03-0.4888image
chr16:15699290-15701319:+CHOLGSVA_HALLMARK_MITOTIC_SPINDLEEER9.6675e-03-0.4888image
chr16:15699290-15701319:+COADGSVA_HALLMARK_MITOTIC_SPINDLEEER3.5606e-05-0.2520image
ENSG00000072864.11,NDE1COADGSVA_HALLMARK_MITOTIC_SPINDLEEAG2.1903e-05-0.2575image
chr16:15699290-15701319:+DLBCGSVA_HALLMARK_G2M_CHECKPOINTEER1.1041e-02-0.3638image
ENSG00000072864.11,NDE1DLBCGSVA_HALLMARK_G2M_CHECKPOINTEAG1.1041e-02-0.3638image
ENSG00000072864.11,NDE1ESCAGSVA_HALLMARK_MITOTIC_SPINDLEEAG3.3715e-02-0.1680image
chr16:15697039-15697557:+ESCAGSVA_HALLMARK_MYOGENESISEER1.1567e-020.4107image
chr16:15699290-15701319:+ESCAGSVA_HALLMARK_MITOTIC_SPINDLEEER3.0039e-02-0.1716image
ENSG00000072864.11,NDE1GBMGSVA_HALLMARK_G2M_CHECKPOINTEAG3.4999e-04-0.2783image
chr16:15699290-15701319:+GBMGSVA_HALLMARK_G2M_CHECKPOINTEER3.6602e-04-0.2775image
ENSG00000072864.11,NDE1HNSCGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.5690e-03-0.1413image
chr16:15699290-15701319:+HNSCGSVA_HALLMARK_MITOTIC_SPINDLEEER1.5439e-03-0.1415image
chr16:15699290-15701319:+KIRCGSVA_HALLMARK_G2M_CHECKPOINTEER2.9854e-02-0.1211image
ENSG00000072864.11,NDE1KIRCGSVA_HALLMARK_KRAS_SIGNALING_DNEAG1.6055e-020.1341image
ENSG00000072864.11,NDE1KIRPGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG4.8945e-05-0.2622image
chr16:15699290-15701319:+KIRPGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEER4.8945e-05-0.2622image
ENSG00000072864.11,NDE1LGGGSVA_HALLMARK_E2F_TARGETSEAG7.1401e-05-0.2143image
chr16:15699290-15701319:+LGGGSVA_HALLMARK_E2F_TARGETSEER7.2753e-05-0.2141image
chr16:15699290-15701319:+LIHCGSVA_HALLMARK_E2F_TARGETSEER1.0163e-03-0.2528image
ENSG00000072864.11,NDE1LIHCGSVA_HALLMARK_E2F_TARGETSEAG1.0163e-03-0.2528image
chr16:15699290-15701319:+LUADGSVA_HALLMARK_KRAS_SIGNALING_UPEER1.7203e-040.1728image
ENSG00000072864.11,NDE1LUADGSVA_HALLMARK_KRAS_SIGNALING_UPEAG1.5372e-040.1737image
chr16:15699290-15701319:+LUSCGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEER2.1457e-040.1651image
ENSG00000072864.11,NDE1LUSCGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEAG2.9558e-040.1615image
ENSG00000072864.11,NDE1MESOGSVA_HALLMARK_G2M_CHECKPOINTEAG4.0373e-03-0.3349image
chr16:15699290-15701319:+MESOGSVA_HALLMARK_G2M_CHECKPOINTEER4.0373e-03-0.3349image
ENSG00000072864.11,NDE1PAADGSVA_HALLMARK_MYC_TARGETS_V1EAG7.2410e-04-0.2687image
chr16:15699290-15701319:+PAADGSVA_HALLMARK_MYC_TARGETS_V1EER6.8866e-04-0.2697image
ENSG00000072864.11,NDE1PCPGGSVA_HALLMARK_MTORC1_SIGNALINGEAG1.6984e-02-0.4728image
ENSG00000072864.11,NDE1PRADGSVA_HALLMARK_SPERMATOGENESISEAG1.2639e-03-0.1611image
chr16:15699290-15701319:+PRADGSVA_HALLMARK_SPERMATOGENESISEER1.9456e-04-0.1869image
chr16:15699290-15701319:+READGSVA_HALLMARK_G2M_CHECKPOINTEER2.0209e-03-0.3129image
ENSG00000072864.11,NDE1READGSVA_HALLMARK_G2M_CHECKPOINTEAG1.4004e-03-0.3232image
chr16:15699290-15701319:+SARCGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEER7.2108e-040.2121image
ENSG00000072864.11,NDE1SARCGSVA_HALLMARK_E2F_TARGETSEAG2.6015e-04-0.2286image
chr16:15699290-15701319:+SKCMGSVA_HALLMARK_G2M_CHECKPOINTEER7.5849e-04-0.1551image
ENSG00000072864.11,NDE1SKCMGSVA_HALLMARK_G2M_CHECKPOINTEAG7.5296e-04-0.1552image
chr16:15697039-15697557:+STADGSVA_HALLMARK_SPERMATOGENESISEER2.8239e-020.3560image
chr16:15699290-15701319:+STADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER7.7306e-030.1428image
ENSG00000072864.11,NDE1STADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG1.7490e-020.1270image
chr16:15699290-15701319:+TGCTGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEER4.2621e-060.3620image
ENSG00000072864.11,NDE1TGCTGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEAG4.2621e-060.3620image
ENSG00000072864.11,NDE1THCAGSVA_HALLMARK_MITOTIC_SPINDLEEAG6.8249e-03-0.1356image
ENSG00000072864.11,NDE1THYMGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG1.7969e-06-0.4232image
chr16:15699290-15701319:+THYMGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEER1.7969e-06-0.4232image
ENSG00000072864.11,NDE1UCECGSVA_HALLMARK_HEME_METABOLISMEAG7.1244e-07-0.3684image
chr16:15699290-15701319:+UCECGSVA_HALLMARK_HEME_METABOLISMEER7.5792e-07-0.3676image
ENSG00000072864.11,NDE1UVMGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG1.3640e-02-0.2856image
chr16:15699290-15701319:+UVMGSVA_HALLMARK_PANCREAS_BETA_CELLSEER1.3640e-02-0.2856image


Top

7. Enriched editing regions and drugs for NDE1


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000072864.11,NDE1ACCLFM.A13EAG2.1247e-02-0.3020image
chr16:15699290-15701319:+ACCLFM.A13EER2.1247e-02-0.3020image
chr16:15699290-15701319:+BLCAJNK.Inhibitor.VIIIEER1.0314e-040.1971image
ENSG00000072864.11,NDE1BLCAAZD.0530EAG1.3864e-05-0.2198image
ENSG00000072864.11,NDE1BRCACGP.082996EAG5.4095e-040.1068image
chr16:15699290-15701319:+BRCAJNK.Inhibitor.VIIIEER5.2237e-040.1072image
chr16:15699290-15701319:+CESCJNK.Inhibitor.VIIIEER1.7096e-030.1795image
ENSG00000072864.11,NDE1CESCJNK.Inhibitor.VIIIEAG1.6116e-030.1804image
ENSG00000072864.11,NDE1CHOLBMS.536924EAG3.0048e-04-0.6427image
chr16:15699290-15701319:+CHOLBMS.536924EER3.0048e-04-0.6427image
ENSG00000072864.11,NDE1COADAG.014699EAG2.2961e-03-0.1865image
chr16:15699290-15701319:+COADErlotinibEER4.4805e-03-0.1747image
ENSG00000072864.11,NDE1DLBCCGP.60474EAG3.5297e-03-0.4130image
chr16:15699290-15701319:+DLBCCGP.60474EER3.5297e-03-0.4130image
chr16:15697039-15697557:+ESCAGSK269962AEER6.3423e-03-0.4406image
ENSG00000072864.11,NDE1ESCAMetforminEAG1.0845e-08-0.4329image
chr16:15699290-15701319:+ESCAMetforminEER1.1493e-08-0.4322image
ENSG00000072864.11,NDE1GBMGefitinibEAG3.6826e-03-0.2276image
chr16:15699290-15701319:+GBMGefitinibEER3.7608e-03-0.2271image
ENSG00000072864.11,NDE1HNSCDMOGEAG4.0957e-040.1578image
chr16:15699290-15701319:+HNSCDMOGEER4.0214e-040.1580image
ENSG00000072864.11,NDE1KIRCLFM.A13EAG9.8655e-04-0.1827image
chr16:15699290-15701319:+KIRCLFM.A13EER3.3999e-03-0.1628image
ENSG00000072864.11,NDE1KIRPFH535EAG2.5115e-020.1464image
chr16:15699290-15701319:+KIRPFH535EER2.5115e-020.1464image
ENSG00000072864.11,NDE1LGGJNK.Inhibitor.VIIIEAG2.3013e-060.2537image
chr16:15699290-15701319:+LGGJNK.Inhibitor.VIIIEER2.3497e-060.2535image
chr16:15699290-15701319:+LIHCGSK269962AEER4.4903e-06-0.3516image
ENSG00000072864.11,NDE1LIHCGSK269962AEAG4.4903e-06-0.3516image
ENSG00000072864.11,NDE1LUADBX.795EAG1.6251e-04-0.1731image
chr16:15699290-15701319:+LUADBX.795EER1.3797e-04-0.1753image
ENSG00000072864.11,NDE1LUSCIPA.3EAG8.0776e-070.2189image
chr16:15699290-15701319:+LUSCIPA.3EER6.7806e-070.2204image
ENSG00000072864.11,NDE1MESOBosutinibEAG9.6371e-03-0.3032image
chr16:15699290-15701319:+MESOBosutinibEER9.6371e-03-0.3032image
chr16:15699290-15701319:+PAADAKT.inhibitor.VIIIEER4.2451e-03-0.2307image
ENSG00000072864.11,NDE1PAADAKT.inhibitor.VIIIEAG4.3581e-03-0.2300image
ENSG00000072864.11,NDE1PCPGBosutinibEAG1.9377e-03-0.5893image
ENSG00000072864.11,NDE1PRADJNK.Inhibitor.VIIIEAG5.1747e-040.1732image
chr16:15699290-15701319:+PRADJNK.Inhibitor.VIIIEER4.6357e-050.2040image
ENSG00000072864.11,NDE1READCI.1040EAG2.4126e-03-0.3078image
chr16:15699290-15701319:+READCI.1040EER1.5242e-03-0.3208image
ENSG00000072864.11,NDE1SARCAZD.0530EAG1.0382e-04-0.2425image
chr16:15699290-15701319:+SARCBicalutamideEER2.8760e-03-0.1874image
chr16:15699290-15701319:+SKCMBMS.754807EER1.1955e-03-0.1493image
ENSG00000072864.11,NDE1SKCMBMS.754807EAG1.2170e-03-0.1491image
ENSG00000072864.11,NDE1STADDMOGEAG3.2125e-030.1571image
chr16:15699290-15701319:+STADDMOGEER2.3079e-030.1631image
chr16:15699290-15701319:+TGCTGNF.2EER7.6190e-07-0.3872image
ENSG00000072864.11,NDE1TGCTGNF.2EAG7.6190e-07-0.3872image
ENSG00000072864.11,NDE1THCABIRB.0796EAG2.0594e-02-0.1162image
chr16:15699290-15701319:+THYMBAY.61.3606EER1.6188e-070.4598image
ENSG00000072864.11,NDE1THYMBAY.61.3606EAG1.6188e-070.4598image
chr16:15699290-15701319:+UCECDasatinibEER3.1150e-04-0.2740image
ENSG00000072864.11,NDE1UCECDasatinibEAG2.7518e-04-0.2764image
ENSG00000072864.11,NDE1UCSAUY922EAG2.3190e-04-0.4730image
chr16:15699290-15701319:+UCSAUY922EER2.3190e-04-0.4730image
ENSG00000072864.11,NDE1UVMAG.014699EAG1.7558e-020.2754image
chr16:15699290-15701319:+UVMAG.014699EER1.7558e-020.2754image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType